Biochemical Monitoring and Management During Pregnancy in Patients with Isovaleric Acidaemia is Helpful to Prevent

D D J Habets1, N C Schaper, H Rogozinski

  • 1Laboratory of Biochemical Genetics, Department of Clinical Genetics, Maastricht University Medical Centre, Noordbuilding, P. Debyelaan 25, 6229 HX, Maastricht, The Netherlands, d.habets@mumc.nl.

JIMD Reports
|February 23, 2013
PubMed

Insights

Isovaleric acidemia (IVA) patients can now have successful pregnancies. Careful monitoring and management during pregnancy are crucial for preventing serious complications, even with varying treatment approaches.

Area of Science:

  • Biochemistry
  • Genetics
  • Maternal-Fetal Medicine

Background:

  • Improved neonatal screening and treatment allow isovaleric acidemia (IVA) patients to reach reproductive age.
  • Pregnancy in IVA patients presents challenges in maintaining metabolic stability for both mother and child.
  • Multidisciplinary care is essential for managing IVA during gestation.

Purpose of the Study:

  • To report on the outcomes of pregnancies in women with isovaleric acidemia (IVA).
  • To compare different management and monitoring strategies for maternal IVA during pregnancy.
  • To assess the safety and efficacy of interventions in IVA pregnancies.

Main Methods:

  • Case report of three women with IVA experiencing five pregnancies.
  • Comparison of metabolic profiles and clinical outcomes under contrasting management approaches.
  • Detailed monitoring included plasma acylcarnitine and amino acid profiles, dietary adjustments, L-carnitine and glycine supplementation, and intravenous glucose/L-carnitine during labor and postpartum.

Main Results:

  • All five pregnancies (including twin gestations) resulted in uncomplicated outcomes for both mother and child, despite varied monitoring intensity.
  • Strictly managed pregnancies with frequent metabolic profiling and interventions showed successful outcomes.
  • Less intensively monitored pregnancies also yielded favorable results, with interventions primarily during hyperemesis gravidarum.

Conclusions:

  • Pregnancy in IVA patients can be managed successfully with diverse monitoring and treatment strategies.
  • While favorable outcomes were observed even with less intensive management, proactive monitoring and management are recommended to prevent metabolic decompensation.
  • This highlights the importance of individualized care plans for pregnant individuals with IVA.

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Diagnosing Acidosis and Alkalosis01:24

Diagnosing Acidosis and Alkalosis

Diagnosing acid-base imbalances involves systematically analyzing arterial blood samples, focusing on three key measurements: pH, bicarbonate (HCO3−) concentration, and carbon dioxide partial pressure (PCO2). This analysis follows a four-step process that helps identify the imbalance's underlying cause and nature.
First, the pH level is assessed to determine whether the blood pH is normal (7.35–7.45), low (acidosis), or high (alkalosis).
Next, the PCO2  and HCO3−  values are examined to...
Diabetic Ketoacidosis l: Introduction01:25

Diabetic Ketoacidosis l: Introduction

DefinitionDiabetic ketoacidosis (DKA) is an acute, life-threatening complication of diabetes mellitus, characterized by a triad of hyperglycemia (blood glucose >250 mg/dL), ketonemia or ketonuria, and metabolic acidosis (arterial pH <7.30 and serum bicarbonate <18 mEq/L). It results from insulin deficiency combined with elevated levels of counterregulatory hormones—glucagon, catecholamines, cortisol, and growth hormone—leading to increased lipolysis, hepatic ketone production, and...
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
Diabetic Ketoacidosis ll: Pathophysiology01:22

Diabetic Ketoacidosis ll: Pathophysiology

Diabetic ketoacidosis (DKA) is a metabolic emergency characterized by hyperglycemia, ketonemia, and metabolic acidosis. It results from severe insulin deficiency and an excess of counterregulatory hormones, leading to uncontrolled lipolysis, ketogenesis, and widespread electrolyte and fluid disturbances.Pathophysiology The central event in DKA is a profound loss of insulin action. Without insulin, glucose uptake in insulin-dependent tissues is impaired, while hepatic glucose production...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...